Results 121 to 130 of about 12,482 (150)
Some of the next articles are maybe not open access.
Management options for minimal hepatic encephalopathy
Expert Review of Gastroenterology & Hepatology, 2008Minimal hepatic encephalopathy (MHE) is a neurocognitive dysfunction that is present in the majority of patients with cirrhosis. MHE has a characteristic cognitive profile that cannot be diagnosed clinically. This cognitive dysfunction is independent of sleep dysfunction or problems with overall intelligence.
openaire +2 more sources
Diagnosis of Minimal Hepatic Encephalopathy
2012Minimal hepatic encephalopathy (MHE) is a neurocognitive disorder that can affect up to 80% of cirrhotic patients. Patients seem clinically unimpaired, but have subtle deficits and psychomotor abnormalities that can only be elicited by specialized tests.
Jennifer Y. Montgomery +1 more
openaire +1 more source
Acetyl-l-Carnitine Treatment in Minimal Hepatic Encephalopathy
Digestive Diseases and Sciences, 2008Minimal hepatic encephalopathy (MHE) is characterized by disturbance of mental state and neuromuscular function. To assess the clinical efficacy of acetyl-L: -carnitine (ALC) in the treatment of MHE, we performed a randomized, double-blind, placebo-controlled study administering ALC in cirrhotic patients with this disease and evaluating their cognitive
MALAGUARNERA, Mariano +7 more
openaire +2 more sources
Rifaximin and Minimal Hepatic Encephalopathy
American Journal of Gastroenterology, 2011Minimal hepatic encephalopathy (MHE) occurs in up to 70% of patients with cirrhosis and has a clear impact on health-related quality of life (HRQOL) in these patients. Antibiotics leading to reductions in circulating ammonia have been used in the past for the treatment of MHE.
openaire +1 more source
Lactulose Management of Minimal Hepatic Encephalopathy
Gastroenterology Nursing, 2019Minimal hepatic encephalopathy has been shown to increase risk of involvement in road traffic accidents and alter quality of life. This systematic review focused on the role of nonabsorbable disaccharides for the management of minimal hepatic encephalopathy.
Donna M, Zucker, Rhoda, Redulla
openaire +2 more sources
Psychometric tests for diagnosing minimal hepatic encephalopathy
Metabolic Brain Disease, 2012While it is consensus that minimal hepatic encephalopathy (mHE) has significant impact on a patient's daily living, and thus should be diagnosed and treated, there is no consensus about the optimal diagnostic tools. At present the most frequently used psychometric methods for diagnosing minimal hepatic encephalopathy are the Inhibitory Control Test and
openaire +2 more sources
Minimal Hepatic Encephalopathy: Simplifying Its Diagnosis
The American Journal of Gastroenterology, 2007Minimal hepatic encephalopathy (MHE) is relatively common and has a significant effect on the quality of life in patients with cirrhosis. However, diagnosing this entity clinically can be quite challenging. Inhibitory control testing (ICT) as a screening tool for diagnosis of MHE has been used clinically for sometime.
Satish Iduru +2 more
openaire +1 more source
Current concepts in minimal hepatic encephalopathy.
Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 2015Minimal hepatic encephalopathy (MHE) defines the presence of neurocognitive impairments in patients with cirrhosis or portal-systemic shunting that show a normal neurologic and psychiatric status on clinical examination. Although ammonia has the central role in MHE pathogenesis, factors such as infection, oxidative stress, manganese or intestinal ...
M A, Badea +3 more
openaire +1 more source